R3
A triple GIP / GLP-1 / glucagon receptor agonist studied for multi-incretin metabolic signaling.
Research Overview
R3 is a synthetic triple agonist targeting the GIP, GLP-1, and glucagon receptors simultaneously. Research models investigate the combined contribution of all three pathways to glucose regulation, lipid metabolism, and energy expenditure.
The triple-receptor mechanism distinguishes it as a next-generation incretin research compound and a frequent subject of comparative agonist studies.
Specifications
| Compound | R3 (LY3437943) |
| Classification | Metabolic research compound |
| Molecular weight | 4,731.32 g/mol |
| Sequence / Form | Synthetic triple-agonist peptide |
| Purity | ≥99% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
